Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12610000544077
ACTRN12610000544077
Recruiting
Phase 3

In high-risk Indigenous infants does an early combination schedule of two pneumococcal conjugate vaccines Synflorix and Prevenar13 provide greater pathogen protection than standard single vaccine schedules.

Menzies School of Health Research0 sites425 target enrollmentJuly 6, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsEar - Other ear disordersOtitis media in Indigenous infantsPneumococcal diseaseNon-typeable Haemophilus influenzae diseaseInfection - Studies of infection and infectious agentsPublic Health - Epidemiology

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Ear - Other ear disorders
Sponsor
Menzies School of Health Research
Enrollment
425
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 6, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Indigenous infants less than 6 weeks of age, living in a remote community and eligible for pneumococcal vaccination.

Exclusion Criteria

  • •less than 32 weeks gestation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Azithromycin bronchiolitis Intervention Study 2: An multicenter intervention study for bronchiolitis in Darwin Townsville and Auckalnd - Comparing severity of disease and readmission of infants given azithromycin or placebo.BronchiolitisRespiratory - Other respiratory disorders / diseases
ACTRN12610000326099Menzies School of Health Research, Darwin219
Completed
Phase 3
Azithromycin versus Amoxicillin for Treatment of Acute otitis media in Aboriginal Children (AATAAC)Acute otitis media in Indigenous children aged 6 months to 6 yearsEar - Other ear disorders
ACTRN12609000691246HMRC330
Active, not recruiting
Phase 1
ewborns smaller than normal who will be randomly and blindly assigned to 21% oxygen or 60% oxygen to be resuscitated to investigate the influence upon mortality and chronic conditions in the neonatal period
EUCTR2011-005717-36-ESInstituto de Investigación Sanitaria La Fe304
Active, not recruiting
Not Applicable
Prediction of mild developmental delay and typical outcome in at risk preterm infants.Infants born at less than 1500g or 32 weeks gestation with increased risk for neurodevelopmental delay.Reproductive Health and Childbirth - Complications of newborn
ACTRN12614000480684Mrs Rebecca Caesar104
Active, not recruiting
Phase 1
Extremely low gestational age infants' PARAcetamol StudyOpen ductus arteriosus of a premature infantTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
EUCTR2018-000566-11-FIniversity of Oulu40